Archive: September 2018
GERD
Laryngopharyngeal Reflux and Functional Laryngeal Disorder: Perspective and Common Practice of the General Gastroenterologist
Dhyanesh A. Patel, MD, Michael Blanco, MD, and Michael F. Vaezi, MD, PhD
Abstract: Laryngopharyngeal reflux (LPR) is an extraesophageal variant of gastroesophageal reflux disease that is associated with chronic cough, hoarseness, dysphonia, recurrent throat clearing, and globus […]
Crohn's Disease
Perianal Fistulas in Patients With Crohn’s Disease, Part 2: Surgical, Endoscopic, and Future Therapies
Stephanie L. Gold, MD, Shirley Cohen-Mekelburg, MD, Yecheskel Schneider, MD, and Adam Steinlauf, MD
Abstract: The treatment of perianal fistulas remains a clinical challenge despite the significant advances that have been made in the management of luminal inflammatory bowel […]
Hepatology
Liver Transplantation for Alcoholic Liver Disease
Eric F. Martin, MD
G&H What is the standard treatment approach to alcoholic liver disease? EM The term alcoholic liver disease (ALD) comprises a spectrum of hepatic injury including […]
IBD
The Use of Mobile Applications in the Management of Patients With Inflammatory Bowel Disease
Matthew J. Hamilton, MD
G&H Currently, how common is the use of mobile applications for managing inflammatory bowel disease? MH The use of mobile applications to manage inflammatory bowel […]
Endoscopy
Cold Snare Resection of Large Duodenal and Colonic Polyps
Cyrus Piraka, MD
G&H What defines a large polyp, and how are such polyps typically managed? CP A large polyp can be defined simply by size, commonly at […]
IBS
Complementary and Alternative Medicine for the Management of Irritable Bowel Syndrome
Linda Nguyen, MD
G&H What are the most commonly used complementary and alternative medicine therapies among patients with irritable bowel syndrome? LN A number of survey studies have […]
HCC
Drugs in Development for Hepatocellular Carcinoma
Lorenza Rimassa, MD
G&H What have been the most recent advances or changes in hepatocellular carcinoma drug development? LR For approximately 10 years, the only drug available for […]
Gastro-Hep News
Gastro-Hep News
Samantha Alleman
US Food and Drug Administration Approves Lenvatinib for Hepatocellular Carcinoma On August 16, 2018, the US Food and Drug Administration (FDA) approved the kinase inhibitor lenvatinib […]
Letter From the Editor
Letter From the Editor
Gary R. Lichtenstein, MD, AGAF, FACP, FACG
Mobile Applications for Inflammatory Bowel Disease Patients Can mobile applications help in the management of patients with inflammatory bowel disease (IBD)? In the Advances in IBD […]